Orbis Medicines, a leader in oral macrocycle drug discovery, today announces the appointment of Mikael Dolsten, M.D., Ph.D., former Chief Scientific O ...
The researchers show that ephrin-B2 regulates the proper spatial activation of VEGFR-2 endocytosis and signaling at the tip cell filopodia. In vitro, endothelial cells from Efnb2-knockout and ...
“Mikael has a long and successful track record overseeing the development of blockbuster therapies and vaccines from discovery ... growth factor receptor (VEGFR) inhibitor Inlyta (axitinib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback